GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
Overview | Financials
Company Name | GlaxoSmithKline Pharmaceuticals Limited |
Symbol | GLAXO.NS |
Currency | INR |
Price | 2,561.15 |
Market Cap | 433,874,176,900 |
Dividend Yield | 1.59% |
52-week-range | 1,449.05 - 3,088 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Bhushan Akshikar |
Website | https://india-pharma.gsk.com |
An error occurred while fetching data.
About GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD